NF2 and meningioma: Altogether, these results suggest that presence of NF2 mutation in the context of an isolated monosomy 22/22q─ confer a low risk of recurrence for WHO grade 1 meningiomas, while complex karyotypes and isolated loss of chromosome 22 in the absence of NF2 mutation would confer a poorer prognosis.